OAC
SANA icon

OMERS Administration Corp’s Sana Biotechnology SANA Stock Holding History

OMERS Administration Corp’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,600
Closed -$194K – 1056
2024
Q2 		$194K Buy
+35,600
New +$284K ﹤0.01% 895

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

OMERS Administration Corp's SANA Position: Q3 2024 in Review

OMERS Administration Corp sold out of Sana Biotechnology (SANA) in Q3 2024, closing a stake of 35,600 shares — an estimated $194K sold.

OMERS Administration Corp first reported a position in SANA in Q2 2024 and held it in 1 quarter. The position peaked at $194K in Q2 2024. 155 funds tracked by Wall St. Rank hold SANA as of Q3 2024.

  • OMERS Administration Corp reported no remaining Sana Biotechnology position as of Q3 2024 after selling out during the quarter.
  • OMERS Administration Corp sold 35,600 Sana Biotechnology shares in Q3 2024, an estimated $194K.
  • OMERS Administration Corp first reported a position in Sana Biotechnology in Q2 2024 and held it in 1 quarter.
  • OMERS Administration Corp's Sana Biotechnology position peaked at $194K in Q2 2024.
  • 155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2024.

Based on OMERS Administration Corp's 13F filing for Q3 2024, filed 13 Nov 2024.